Prime Medicine GAAP EPS of -$1.35, revenue of $4.63M
Source: SeekingAlpha
2026-03-03 15:38:43 ET
More on Prime Medicine
- Prime Medicine, Inc. (PRME) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Prime: Maintaining 'Buy' On Solidified Catalysts For Wilson's Disease And Beyond
- Prime Medicine slips after Q4 updates
- Seeking Alpha’s Quant Rating on Prime Medicine
- Historical earnings data for Prime Medicine
Read the full article on Seeking Alpha
For further details see:
Prime Medicine GAAP EPS of -$1.35, revenue of $4.63M
First Trust Heitman Global Prime Real Estate ETF
NASDAQ: PRME
PRME Trading
3.52% G/L:
$4.26 Last:
826,640 Volume:
$4.16 Open:
PRME Latest News
March 03, 2026 08:00:00 am
Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates
PRME Stock Data
$629,079,643
97,403,551
13.07%
59
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
